New York Prevention Care Manager Project / Medicaid Managed Care Organization Version
- Develop and evaluate an enhanced telephone support intervention (Prevention Care
Manager [PCM]) to promote colorectal, cervical, and breast cancer screening more widely
among women enrolled in a Medicaid Managed Care Organization (MMCO).
- Explore the impact of patient, Community/Migrant Health Center (C/MHC), and MMCO
characteristics on cancer screening status and the impact of the intervention.
- Evaluate the impact of the enhanced PCM intervention upon colorectal, breast, and
cervical cancer screening rates.
- Compare the status of women who are up-to-date (UTD) on CRC screening versus the UTD
status of cervical cancer and breast cancer screening.
OUTLINE: This is a randomized, controlled study. The study is conducted in 2 parts.
- Part 1 (barrier interview and pilot testing): Patients are stratified according to
primary language and whether or not they have had an outpatient visit in the past year.
- Barrier interview: Patients undergo a 15-30 minute interview to determine barriers
they face preventing them from receiving recommended cancer screenings and
healthcare, as well as facilitators which have encouraged them to be screened.
- Pilot testing: Patients from the barrier interviews and other eligible Medicaid
Managed Care Organization (MMCO) patients receive scripted telephone calls from a
Prevention Care Manager to assist them in getting up-to-date on their cancer
screening tests over 3 months.
- Part 2 (randomized control trial): Patients are stratified according to treatment
center (Community/Migrant health center vs Diagnostic and Treatment Center) and age.
Patient are randomized to 1 of 2 intervention arms.
- Arm I (Prevention Care Manager): Patients are stratified according to the number
of tests for which they are up-to-date at baseline. Patients receive reminder
letters encouraging them to contact their primary care provider for colorectal,
breast, and cervical cancer screening and 3 to 4 telephone support calls to help
them become up to date for colorectal, breast, and cervical cancer screening.
- Arm II (usual care): Patients receive usual care according to their primary care
In both arms, patients are followed for 18 months.
PROJECTED ACCRUAL: A total of 2,600 patients will be accrued for this study.
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Percentage of patients up-to-date (UTD) for colorectal cancer (CRC) screening
Comparison of women in PCM and UC arms who received colon cancer screening tests during 18 month intervention period.
Allen J. Dietrich, MD
Norris Cotton Cancer Center
United States: Institutional Review Board
|Clinical Directors Network, Incorporated||New York, New York 10018|